Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q07644 (
polypeptide
)
72,197
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Nuclear factor-erythroid number 2 (NF-E2) is a positive regulatory, DNA binding transcription factor for gene expression in erythroid and megakaryocytic cells. To further understand the mechanisms of NF-E2 function, we used expression cloning to identify coregulators interacting with the erythroid-specific subunit of NF-E2, p45. We have isolated a protein,
NAPP2
, which contains an aspartic-acid- and glutamic-acid-rich region and a nuclear localization signal. The gene encoding
NAPP2
, PEX14, is located on chromosome 1p36 and is ubiquitously expressed. The domains of interaction in vitro and in vivo between p45 and
NAPP2
were mapped by a yeast two-hybrid system and cotransfection experiments. In mammalian cell culture, ectopically expressed
NAPP2
inhibited p45-directed transcriptional activation. Furthermore,
NAPP2
functions as a corepressor and interacts specifically with histone deacetylase l (HDAC1), but not HDAC2 or HDAC3.
NAPP2
is thus potentially a negative coregulator of NF-E2.
NAPP2
is identical to PEX14, an integral membrane protein essential for protein docking onto the peroxisomes. These studies have identified a novel, bifunctional protein capable of acting as a transcriptional corepressor and a
polypeptide
transport modulator. They also suggest that NF-E2 may function both positively and negatively in the transcription regulation of specific erythroid and megakaryocytic genes.
...
PMID:NAPP2, a peroxisomal membrane protein, is also a transcriptional corepressor. 1186 72